11th week of 2019 patent applcation highlights part 8 |
Patent application number | Title | Published |
20190076409 | USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY | 2019-03-14 |
20190076410 | Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions Thereof | 2019-03-14 |
20190076411 | STABLE LIQUID INECTABLE SOLUTION OF MIDAZOLAM AND PENTAZOCINE | 2019-03-14 |
20190076412 | USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS | 2019-03-14 |
20190076413 | PHARMACEUTICAL COMPOSITIONS | 2019-03-14 |
20190076414 | FEXOFENADINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM | 2019-03-14 |
20190076415 | METHODS OF TREATING BEHAVIORAL SYNDROMES USING PIPRADROL | 2019-03-14 |
20190076416 | PIM KINASE INHIBITORS IN COMBINATION WITH RNA SPLICING MODULATORS/INHIBITORS FOR TREATMENT OF CANCERS | 2019-03-14 |
20190076417 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION | 2019-03-14 |
20190076418 | Pharmaceutical Composition | 2019-03-14 |
20190076419 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2019-03-14 |
20190076420 | Dosing of Cabozantinib Formulations | 2019-03-14 |
20190076421 | RESPIRATORY INFECTION TREATING AGENT | 2019-03-14 |
20190076422 | USE OF AN H4 AGONIST MOLECULE FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS | 2019-03-14 |
20190076423 | COMBINATION THERAPY FOR PROLIFERATIVE DISEASES | 2019-03-14 |
20190076424 | GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT CERVICAL CANCER | 2019-03-14 |
20190076425 | METHODS OF TREATMENT WITH CYP3A4 SUBSTRATE DRUGS | 2019-03-14 |
20190076426 | NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2019-03-14 |
20190076427 | COMBINATION OF AN INHIBITOR OF PARP WITH AN INHIBITOR OF GSK-3 OR DOT1L | 2019-03-14 |
20190076428 | FREEZE DRIED DRUG NANOSUSPENSIONS | 2019-03-14 |
20190076429 | METHODS FOR TREATING FRIEDREICH'S ATAXIA WITH ETRAVIRINE | 2019-03-14 |
20190076430 | OUTPATIENT MODIFIED RAPID DETOXIFICATION FOR ADDICTION TO ALCOHOL AND DRUGS | 2019-03-14 |
20190076431 | SRC INHIBITOR TO BLOCK CELL SURFACE GRP78 EXPRESSION | 2019-03-14 |
20190076432 | 1-[2-(AMINOMETHYL)BENZYL]-2-THIOXO-1,2,3,5-TETRAHYDRO-4H-PYRROLO[3,2-d]PYR- IMIDIN-4-ONES AS INHIBITORS OF MYELOPEROXIDASE | 2019-03-14 |
20190076433 | METHODS OF TREATING CANCER | 2019-03-14 |
20190076434 | METHODS OF TREATING PERIPHERAL VASCULAR DISEASES, INCLUDING SYSTEMIC SCLEROSIS VASCULOPATHY | 2019-03-14 |
20190076435 | SALTS AND SOLID FORM OF A BTK INHIBITOR | 2019-03-14 |
20190076436 | MACROCYCLIC COMPOUNDS AS ROS1 KINASE INHIBITORS | 2019-03-14 |
20190076437 | MACROCYCLIC COMPOUNDS AS ROS1 KINASE INHIBITORS | 2019-03-14 |
20190076438 | ANTI-ERBB2 ANTIBODY-DRUG CONJUGATE AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 2019-03-14 |
20190076439 | AMINOPHENOTHIAZINES FOR MODULATING THE NUMBER OF SYNAPSES | 2019-03-14 |
20190076440 | TREATMENT OF TISSUE DISORDERS | 2019-03-14 |
20190076441 | METHOD OF TREATING HYPERTENSION | 2019-03-14 |
20190076442 | PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION CONTAINING BIMATOPROST AND TIMOLOL | 2019-03-14 |
20190076443 | METHODS OF TREATING OBESITY USING ANTIOXIDANT INFLAMMATION MODULATORS | 2019-03-14 |
20190076444 | COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM | 2019-03-14 |
20190076445 | Methods for Suppressing Allergic Reactions | 2019-03-14 |
20190076446 | COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE | 2019-03-14 |
20190076447 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS | 2019-03-14 |
20190076448 | METHODS OF TREATING OSTEONECROSIS WITH LLP2A-BISPHOSPHONATE COMPOUNDS | 2019-03-14 |
20190076449 | THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES | 2019-03-14 |
20190076450 | SUBSTITUTED BICYCLIC COMPOUNDS | 2019-03-14 |
20190076451 | Antibiotic Kit and Composition and Uses Thereof | 2019-03-14 |
20190076452 | THERAPEUTIC COMBINATIONS FOR TREATING NEOPLASIA | 2019-03-14 |
20190076453 | TOPICAL WASH COMPOSITION FOR USE IN ACNE PATIENTS | 2019-03-14 |
20190076454 | CALCIUM GLUCONATE SOLUTIONS IN FLEXIBLE CONTAINERS | 2019-03-14 |
20190076455 | TREATMENT OF LEUKEMIA VIA THE ADMINISTRATION OF DOT1L INHIBITOR PINOMETOSTAT | 2019-03-14 |
20190076456 | COMPOSITIONS AND METHODS FOR LIVER DISEASES | 2019-03-14 |
20190076457 | NANOPARTICLE TO TARGET CANCER | 2019-03-14 |
20190076458 | METHODS AND COMPOSITIONS FOR ATTENUATING GENE EXPRESSION MODULATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES | 2019-03-14 |
20190076459 | ENHANCING PLASMIN ACTIVITY TO PREVENT SOFT TISSUE CALCIFICATION | 2019-03-14 |
20190076460 | An mRNA cancer vaccine encoding human GM-CSF fused to multiple tandem epitopes | 2019-03-14 |
20190076461 | MATERIALS AND METHODS FOR TREATING HYPOXIC CONDITIONS | 2019-03-14 |
20190076462 | AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF | 2019-03-14 |
20190076463 | NOVEL RNA CONSTRUCT AND METHODS OF USE THEREOF FOR ENHANCING THE THERAPEUTIC EFFECTS OF CYTOTOXIC CELLS AND STEM CELLS | 2019-03-14 |
20190076464 | CYTIDINE DEAMINASE INHIBITORS FOR THE TREATMENT OF PANCREATIC CANCER | 2019-03-14 |
20190076465 | MODULATORS OF SMAD7 EXPRESSION | 2019-03-14 |
20190076466 | REDUCED SODIUM POLOXAMER-188 FORMULATIONS AND METHODS FOR USE | 2019-03-14 |
20190076467 | ANTIVIRAL CONJUGATES OF POLYANIONIC POLYMER AND ANTIVIRAL DRUG | 2019-03-14 |
20190076468 | ENHANCED IMMUNE RESPONSE UPON TREATMENT WITH NITRIC OXIDE | 2019-03-14 |
20190076469 | TOPICALLY ADMINISTERED STRONTIUM-CONTAINING COMPLEXES FOR TREATING PAIN, PRURITIS AND INFLAMMATION | 2019-03-14 |
20190076470 | ANTI-HEMORRHAGING COMPOSITIONS | 2019-03-14 |
20190076471 | DIETARY SUPPLEMENTS, ADDITIVES, AND DRENCH FOR LIVESTOCK | 2019-03-14 |
20190076472 | HYPERAMMONEMIA THERAPY FOR CHILDREN SUFFERING FROM UREA CYCLE DISORDERS | 2019-03-14 |
20190076473 | AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS | 2019-03-14 |
20190076474 | Induction of Regulatory B Cells for the Treatment of Immune Mediated Diseases | 2019-03-14 |
20190076475 | MATERIALS AND METHODS FOR INCREASING IMMUNE RESPONSES | 2019-03-14 |
20190076476 | NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS | 2019-03-14 |
20190076477 | NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS | 2019-03-14 |
20190076478 | CANINE BLOOD PLATELET PREPARATIONS | 2019-03-14 |
20190076479 | ADIPOSE TISSUE-DERIVED STEM CELLS FROM TRANSGENIC PORCINE ANIMALS FOR HUMAN USE | 2019-03-14 |
20190076480 | THERAPY USING CARDIAC STEM CELLS AND MESENCHYMAL STEM CELLS | 2019-03-14 |
20190076481 | Method to amplify cardiac stem cells in vitro and in vivo | 2019-03-14 |
20190076482 | ENHANCED ORGANOID FORMATION AND INTESTINAL STEM CELL RENEWAL | 2019-03-14 |
20190076483 | HONEYBEE POLLEN COMPOSITION | 2019-03-14 |
20190076484 | Biomarkers For Early Determination Of Severity Of Influenza Related Disease | 2019-03-14 |
20190076485 | ANTI-OBESITY MICROBIOTA COMPOSITIONS AND PREPARATION METHODS AND USES THEREOF | 2019-03-14 |
20190076486 | USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS | 2019-03-14 |
20190076487 | ANAEROPLASMATALES FOR USE IN THE TREATMENT OR PREVENTION OF AN INFLAMMATORY DISORDER OF THE DIGESTIVE SYSTEM | 2019-03-14 |
20190076488 | FEED ADDITIVE COMPOSITION | 2019-03-14 |
20190076489 | GENE EXPRESSION SYSTEM FOR PROBIOTIC MICROORGANISMS | 2019-03-14 |
20190076490 | SYNBIOTICS COMBINATION FOR BRAIN IMPROVEMENT | 2019-03-14 |
20190076491 | METHODS OF TREATING SUBSTANCE ABUSE RELATED DISEASES OR DISORDERS | 2019-03-14 |
20190076492 | IMMUNITY-INDUCING AGENT | 2019-03-14 |
20190076493 | ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN OR ACTIVE FRAGMENT | 2019-03-14 |
20190076494 | LUNG CANCER THERAPY WITH A PARVOVIRUS | 2019-03-14 |
20190076495 | SYNERGISTIC COMBINATIONS OF CAFFEINE, GINKGO BILOBA AND BETA-PHENYLETHYLAMINE | 2019-03-14 |
20190076496 | POLYSACCHARIDE DIGESTION INHIBITOR | 2019-03-14 |
20190076497 | ORAL AND INTESTINAL HEALTH PRODUCTS | 2019-03-14 |
20190076498 | FEIJOA FRUIT EXTRACT | 2019-03-14 |
20190076499 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEARING LOSS COMPRISING OAT EXTRACT AS AN ACTIVE INGREDIENT | 2019-03-14 |
20190076500 | COMBINATIONS COMPRISING FXR AGONISTS | 2019-03-14 |
20190076501 | OXYTOCIN IMPROVES TREATMENT OF OBSTRUCTIVE SLEEP APNEA | 2019-03-14 |
20190076502 | MEDICAL USE OF CREG PROTEIN | 2019-03-14 |
20190076503 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER OR CANCER METASTASIS, CONTAINING FSTL1 PROTEIN AS ACTIVE INGREDIENT | 2019-03-14 |
20190076504 | COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS | 2019-03-14 |
20190076505 | IMMUNITY INDUCER | 2019-03-14 |
20190076506 | ACYLATED GLUCAGON ANALOGUES | 2019-03-14 |
20190076507 | Artificial Red Blood Cell Having Ability to Inhibit Conversion of Hemoglobin into Methemoglobin | 2019-03-14 |
20190076508 | LYSOSOMAL ACID LIPASE AND PPAR GAMMA LIGANDS AS IMMUNE THERAPIES FOR CANCER TREATMENT | 2019-03-14 |